WO2007052876A1 - Stability of secondary metabolite mass production through syncronized plant cell cultures - Google Patents
Stability of secondary metabolite mass production through syncronized plant cell cultures Download PDFInfo
- Publication number
- WO2007052876A1 WO2007052876A1 PCT/KR2006/001544 KR2006001544W WO2007052876A1 WO 2007052876 A1 WO2007052876 A1 WO 2007052876A1 KR 2006001544 W KR2006001544 W KR 2006001544W WO 2007052876 A1 WO2007052876 A1 WO 2007052876A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- plant
- culture
- cambium
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Definitions
- Plant has been used very importantly not only as our food supply but also as the source of extensive chemical substances including, pharmaceuticals, fragrances, colors, agricultural chemicals and dyes etc.
- Biologically active compounds that are produced from plants are mostly secondary metabolites.
- secondary metabolites such as alkaloid, allergen, amino acid, anthraquinone, antileukaemic agent, antimicrobial agent, antitumor agent, antiviral agent, enzyme, flavonoids, insecticide, opiate, perfume, pigment, vitamin, and polysaccride etc., because most of them work as physiologically active substances.
- secondary metabolites such as alkaloid, allergen, amino acid, anthraquinone, antileukaemic agent, antimicrobial agent, antitumor agent, antiviral agent, enzyme, flavonoids, insecticide, opiate, perfume, pigment, vitamin, and polysaccride etc.
- KR patent 0130100 production of biologically active substances through plant cell culture has more advantages than direct extraction from the plant.
- Plant cell culture is considered as an optimal method for continual production which is not influenced by environment and for solving the pending problems like destruction of ecology.
- Nail & Roberts (2004) indicated slow growth rate and low productivity of the plant cell culture for the secondary metabolite production.
- there are studies of the optimization of the media, culture conditions, process and elicitation for higher productivity etc. Zhong 2002).
- various media was used to culture diverse Taxus for the increase in cell growth rate and paclitaxel productivity. Based on the results of the experiments, elicitation conditions for paclitaxel mass production was indicated.
- variability is still a major issue for the production of paclitaxel from Taxus and other valuable substances from numerous plant systems.
- Plant cell lines derived from single cells have lower variability than the cell lines derived from multiple cells! this results in higher productivity.
- stem, root, seed, needle and leaf were used as the best explants for cell line induction.
- These stem, root, seed, needle and leaf are tissues that are composed of the cells with distinct functions and morphology. Callus, cell lines derived from these tissues is not of one kind. Therefore, there are limitations on the attempts to reduce the productivity variation of the callus derived from the tissues consisted of multiple cells.
- Cell aggregation One of the distinguishing characteristics of plant cell culture is cell aggregation. According to the patent 0364478, diameter of the plant cell is 30-300 ⁇ m which is about 30 times bigger than the animal cell. Because plant cell walls have natural tendency to adhere together, it is not possible to obtain suspension which consists only of dispersed single cells. The proportion and the size of cell aggregates vary according to plant variety and the medium in which the culture is grown. Nail & Roberts indicated that cell aggregation leads to a difference in local environment between interior and exterior of the cells, which can result in culture heterogeneity and ultimately leads to changes in growth and metabolism.
- suspension culture is to obtain pure single cells.
- filtration, maceration and protoplast culture by using enzyme were used.
- filtration and maceration do not provide complete pure single cells.
- Protoplast culture technique which eliminates the cell wall is the most reliable method for generating single cells, but the enzyme used for the protoplast culture cause cell wall damages or breakages that result in the change of cell physiology.
- hydrophobic secondary metabolites such as paclitaxel can be stored in the cell wall, so the changes in the cell wall have profound relationship with productivity.
- cell aggregation has long been a major obstacle to the accurate measurement of cell growth by number and to biochemical assays to individual cells. According to Nail & Roberts (2004), if single cell culture is possible, it will readily provide faster information about the behavior of cell units in the culture such as biosynthesis, storage, and degradation etc. of secondary metabolites.
- the dedifferentiated cell line which is callus, shows great variability in the production of secondary metabolites due to somaclonal variation.
- Callus derived from the permanent tissues such as leaves, stem, root and seed that are composed of the cells with distinct functions and morphology usually show dramatical changes even on slightly different micro-environments because it is a secondary meristem formed by dedifferentiation. Due to this sensitivity, Hirasuna et al.(1996) investigated to identify the cell culture conditions, especially initial cell density, subculture interval and temperature, and to maintain them as precisely as possible.
- Bioreactor In order to produce secondary metabolites through plant cell culture for commercialization, scale up is essential. Bioreactor has been applied for mass production after many patents and articles were published, reporting about successful production of metabolites through cell culture in a laboratory scale. According to patent 0290004, application of bioreactor for mass production provides very different culture environment from the flask in a laboratory scale which results in the decrease in growth rate and productivity and change in the metabolites. When the bioreactor is applied for mass production, changes in growth rate, productivity and metabolites have become problems in commercialization of biologically active substances through cell culture. In the scale up of plant cell cultures, bioreactor which receives the air through exterior power or the bioreactor with impeller by considering the efficiency of the mixing and aeration are preferred.
- Cryopreservation allows the long term cell maintenance by ceasing most of the metabolism of the cells in the extremely low temperature. It signifies the recovery of the cells without genetic, characteristics and biosynthetic variation after cryopreservation. By using cryopreservation, lost of the cells from contaminations could be eliminated and the genetic variation in the continuous cell lines could be minimized.
- cGMP the preservation of the cell lines for a long period is mandatory for the stable supply of raw materials.
- cultured animal cells could undergo cryopreservation for many years, but the similar cryopreservation technique is much more challenging for cultured plant cells. Cultured plant cells are heterogeneous and show diversity in physiology and morphology. Therefore, plant suspension cells require many processes for cryopreservation and inadequate cryopreservation could cause variability.
- elicitation is one of the most effective ways to promote the secondary metabolites production in cell culture. Elicitation encourages secondary metabolite synthesis, but it induces cell growth inhibition and the rapid decrease in the cell viability. Hence, secondary metabolite synthesis by elicitation could be maintained only for a short period and it is very limited. As Wang et al. (2001) presented, perfusion cultivation is a strategy to minimize these negative effects by elicitation and to maximize the productivity.
- Taxus media cell line (Wickremesinhe and Arteca 1994) did not excrete any. Consequently, establishing the cell line that has outstanding secretion ability is required.
- Procambium or cambium is a lateral meristem that is located on the lateral side of the plant. In the gymnosperm and woody dicotyledon plants, there is a hypertrophic growth due to the continual activity of the procambium or cambium; as a result, giant plants having more than 11,000 years of the growth rings exist. In genetics, meristems could be classified as primary and secondary meristem. Primary meristem represents the meristem that forms during embryogenesis and participates in the plant growth after seed germination. Secondary meristem represents the meristem that is formed by dedifferentiation of the plant permanent tissue. Cambium is a primary meristem with meristematic continuity derived from the procambium without the intervene of the permanent tissue.
- procambium or cambium culture has been used for rapid mass propagation of the cells.
- cambium explants were prepared as follows: after the bark was peeled off, two longitudinal cuts, approximately lmm deep in order to reach the xylem, were made into the woody stem at an interval of 5mm. They called these explants 'cambium', which was constituted of part of the phloem, cambium and a small chip of xylem (Jouira et al., 1998).
- the objective of this invention is to generate the method to produce single cell clone by separating and culturing only the procambium or cambium from the twig or stem.
- the goal of this invention is to solve the variation in plant cell culture and to generate stable production method for plant biologically active substances by separating the procambium or cambium purely through combining the methods of cell and physiological chemistry separation to the preceding physical separation method that utilizes the scalpel.
- Another purpose of this invention is to separate and culture only the procambium or cambium from the Taxus twig and to generate the method of paclitaxel production.
- this invention allows us to obtain single cell clone by separating and culturing the procambium or cambium from the Taxus twig or stem and provides the method of stable cell proliferation and paclitaxel production.
- the method of stable cell proliferation and paclitaxel production by obtaining single cell clone includes:
- Cell line of this invention allows stable production of biologically active substances due to less change in the cell growth rate and growth pattern during the long term culture. It is also optimal for the mass production in commercial level because it is less sensitive to shear in the bioreactor compared to the cell lines derived from the preceding techniques due to less aggregation and multiple vacuoles,
- Metabolite activation can be stimulated by supplementing conditioning factors to this cell line and cell vitality and biosynthesis can be extended as the cells releasing considerable amount of production into the extracellular media through perfusion culture.
- High recovering rate after cryopreservation due to homogeneity and division ability of this cell line devises the establishment of cell bank.
- Figure 1 is the part which was separated during the induction of single cell clone from the procambium or cambium.
- Figure 2 is the growth rate expressed by the total biomass production of three different cell cultures derived from procambium or cambium, embryo and needle.
- Figure 3 is the image of cell aggregation of the cultures derived from two different tissues (embryo or needle and cambium).
- Figure 4 is the effect of elicitation on paclitaxel production during Taxus suspension culture.
- Figure 5 is the effect of conditioning factors on paclitaxel production during Taxus suspension culture.
- Seed, needle, twig of the yew tree were collected. After collecting the materials, they were deposited in the solution of 100mg/L of antioxidant, ascorbic acid (L-ascorbic acid, DUCHEFA, The Netherlands) immediately and transferred and preserved. They were surface sterilized by considering the morphology and physiological characteristics of the materials.
- CD Seed After sterilizing the seeds with 70 % ethanol for one minute, they were immersed in 1 % Clorox solution for 48 hours and were washed 3 to 4 times with sterile water. Next, embryo was separated from the seed in the solution of 0.5% PVP(poly vinyl pyrrolidone, DUCHEFA, The Netherlands) and 50mg/L of ascorbic acid(L-ascorbic acid, DUCHEFA, The Netherlands), and 70mg/L of citric acid(DUCHEFA, The Netherlands) and cultured on the callus induction media.
- PVP poly vinyl pyrrolidone
- Procambium or cambium preparation from the twig or stem By holding the xylem which is the center region of the twig or stem with the tweezers, phloem and cortex and epidermis tissues including the procambium or cambium were peeled off. This peeled tissue that contained procambium or cambium were laid on the media; procambium or cambium was allowed to touch the surface of the media.
- mB5 modified Gamberg's B5 medium
- MS Merashige & Skoog medium
- WPM Liyed & McCown
- SM schenk & Hildebrand medium
- LP Quoirin & Lepiovre
- composition Contents (mg/L)
- the cultures were grown on the media that was supplemented with a p lant g rowth regulator, auxin (l-3mg/L) in the dark at 25+1 0 C.
- Procambium or cambium was composed of homogeneous cells, so its cell division was uniform and proliferation occurred in the form of a plate.
- the tissue containing the phloem and cortex and epidermis proliferated in irregular form because there was a discrepancy of cell division due to the composition of many kinds of cells.
- Procambium or cambium was homogeneous and the tissue containing phloem and cortex and epidermis was heterogeneous, so the self-split of the layer seemed to be the result of different division rate.
- composition Contents (mg/L) ⁇ norganic salts Ca(NO 3 )Z 471.26
- Explant source aggregates aggregates aggregates population
- Moderate cell aggregates 1 x 10 3 ⁇ m;
- Embryo and needle-derived and procambium or cambium-derived cultures were cultured in 3L airlift bioreactor (Sung-Won SciTech, Korea) in the dark at 25 ⁇ 1C°.
- Doubling time of the embryo and needle-derived cultures in the flask was 12 days but it was lengthened to 21 days in the bioreactor. It was because of the growth ring formation and rapid decrease of cell viability due to sensitiveness to shear by cell aggregation and rigid cell wall. Doubling time of procambium or cambium-derived cultures was 4 to 5 days and there was no difference in the flask and the bioreactor, rather it was shortened in the bioreactor (Table 4). Procambium or cambium-derived cultures formed very small growth ring in the bioreactor and the growth ring was dissolved easily by agitating the media with a simple stimulus. Moreover, there was no decrease in cell viability due to less sensitivity to shear by less cell aggregation and multiple vacuoles. Table 4
- Elicitor controls molecular signal in plant cells and is widely used for the increase of secondary metabolite productivity.
- methyl jasmonate as an elicitor and 10 other kinds of elicitors.
- paclitaxel production was very effective with the treatments of methyl jasmonate, chitosan and phenylanine ( Figure 4).
- Plant derived secondary metabolites are produced when the cells are growing or when the cells stopped growing. Therefore, two stage cultures are suitable for the production of metabolites like paclitaxel whose cell growth stage and metabolite production stage are separated. In the first stage, cells were proliferated in a large scale by optimizing the cell growth and in the second stage, the culture condition was changed for the optimization of metabolites production.
- Taxo yield (r ⁇ g/kg) Taxol release
- paclitaxel release of the cell to the media was different. Releasing ability of procambium or cambium- derived cultures was superior to the cultures of the preceding techniques. Moreover, application of perfusion culture facilitated the release of secondary metabolites to the media. Improvement in the extracellular release of secondary metabolites through procambium or cambium- derived single cell clone by exchanging the media periodically had great importance because it allowed continuous recycle of the biomass and simple purification.
- periodical exchange of the media in the procambium or cambium-derived single cell clone culture can be considered as a stable method of producing valuable metabolites in the long term culture, because it prevents feedback inhibition of accumulated metabolites in the cell, degradation and conversion of the metabolites in the media.
- suspension cells were pre-cultured in the media containing 0.16M of manitol for 3 days at the room temperature and then maintained at 4 0 C for 3 hours. Cells were harvested and placed into 4 ml cryovial which had the media containing 40% ethylene glycoKSigma, USA) and 30% sorbitoKDUCHEFA, The Netherlands) and cultured for 3 minutes at 4 0 C.
- Suspension cells that were treated with cryopreservatives were frozen after the cells were soaked in the liquid nitrogen. For thawing, cultured cells in the liquid nitrogen for more than 10 minutes were thawed in the 40 °C water bath for 1-2 minutes. For the re-growth of the cells, cryopreserved cells were transferred onto the semi-solid growth media (Table 1) containing 0.5 M sorbitol and alleviated at the room temperature for 30 minutes. Cells were cultured on the semi-solid growth media containing 0.1M sorbitol for 24 hours. And then, the cells were cultured on the semi-solid growth media without sorbitol for 24 hours, twice. Cell viability was evaluated.
- paclitaxel contents were analyzed.
- Cell mass was measured after drying the cells completely with vacuum desicator (Sam Shin Glass, Korea). About lOOmg (dry weight) of the cells were mixed with 4 ml solution (1:1 v/v) of methanoKSigma, USA) and methylchloride(Sigma, USA) and were extracted by ultrasonic cleaner(Branson, USA) for 3 times in one hour interval at the room temperature. Cells were fully dried and extracted several times by using 4ml of methylchloride. Separated organic solvent layer was vacuum dried and the remaining was dissolved in 1 ml of methanol. Dissolved extract was agitated equally by ultrasonic cleaner. Then, after centrifugation, the pellet was removed (8,000gX5 min).
- HPLC High Performance Liquid Chromatography, Shiseido, Japan
- Capcell pak C18, MGII, 5um, 3.0mmX250mm, Shiseido, Japan
- water and acetonitril (Burdick & Jackson, USA) (50:50, v/v) were combined for the mobile phase and dropped regularly with the speed of 0.5ml/min.
- UV-VIS detector (227nm, Shiseido, Japan) was used.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES06757522.5T ES2546108T3 (en) | 2005-10-31 | 2006-04-25 | Stability of mass production of secondary metabolites through synchronized plant cell cultures |
BRC10619656-0A BRPI0619656C1 (en) | 2005-10-31 | 2006-04-25 | method for isolating a single cell clone derived from a plant procambium, resulting clone, method of producing biologically active plant substances, and method of preserving a plant cell line |
JP2008538791A JP5211296B2 (en) | 2005-10-31 | 2006-04-25 | Stabilization of mass production of secondary metabolites by synchronized plant cell culture |
AU2006309568A AU2006309568B8 (en) | 2005-10-31 | 2006-04-25 | Stability of secondary metabolite mass production through synchronized plant cell cultures |
CN200680039945.8A CN101297028B (en) | 2005-10-31 | 2006-04-25 | The stabilization method of the secondary metabolite batch production of being cultivated by synchronized plant cell |
PL06757522T PL1951863T3 (en) | 2005-10-31 | 2006-04-25 | Stability of secondary metabolite mass production through syncronized plant cell cultures |
CA2627533A CA2627533C (en) | 2005-10-31 | 2006-04-25 | Stability of secondary metabolite mass production through syncronized plant cell cultures |
EP06757522.5A EP1951863B1 (en) | 2005-10-31 | 2006-04-25 | Stability of secondary metabolite mass production through syncronized plant cell cultures |
US12/063,929 US8017397B2 (en) | 2005-10-31 | 2006-04-25 | Isolated population of plant single cells and method of preparing same |
US12/117,783 US8053238B2 (en) | 2005-10-31 | 2008-05-09 | Isolated population of plant single cells and method of preparing the same |
US12/992,810 US9585923B2 (en) | 2005-10-31 | 2009-05-14 | Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient |
US12/889,126 US8329471B2 (en) | 2005-10-31 | 2010-09-23 | Isolated population of plant single cells and method of preparing same |
US12/889,026 US20110033903A1 (en) | 2005-10-31 | 2010-09-23 | Isolated population of plant single cells and method of preparing same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2005-0103445 | 2005-10-31 | ||
KR20050103445 | 2005-10-31 |
Related Child Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/063,929 A-371-Of-International US8017397B2 (en) | 2005-10-31 | 2006-04-25 | Isolated population of plant single cells and method of preparing same |
US6392908A Continuation-In-Part | 2005-10-31 | 2008-02-15 | |
US12/117,783 Continuation-In-Part US8053238B2 (en) | 2005-10-31 | 2008-05-09 | Isolated population of plant single cells and method of preparing the same |
US12/992,810 Continuation-In-Part US9585923B2 (en) | 2005-10-31 | 2009-05-14 | Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient |
US12/889,026 Division US20110033903A1 (en) | 2005-10-31 | 2010-09-23 | Isolated population of plant single cells and method of preparing same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007052876A1 true WO2007052876A1 (en) | 2007-05-10 |
Family
ID=38006007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2006/001544 WO2007052876A1 (en) | 2005-10-31 | 2006-04-25 | Stability of secondary metabolite mass production through syncronized plant cell cultures |
Country Status (12)
Country | Link |
---|---|
US (2) | US8017397B2 (en) |
EP (2) | EP2386626B1 (en) |
JP (2) | JP5211296B2 (en) |
KR (2) | KR101064519B1 (en) |
CN (1) | CN101297028B (en) |
AU (1) | AU2006309568B8 (en) |
BR (1) | BRPI0619656C1 (en) |
CA (1) | CA2627533C (en) |
ES (1) | ES2546108T3 (en) |
PL (1) | PL1951863T3 (en) |
RU (1) | RU2398874C2 (en) |
WO (1) | WO2007052876A1 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2220211A2 (en) * | 2007-09-21 | 2010-08-25 | Unhwa Corporation | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same |
WO2010137879A2 (en) * | 2009-05-26 | 2010-12-02 | 주식회사 운화 | Plant stem cell derived from cambium of family salicaceae and method for isolating and culturing same |
JP2011500559A (en) * | 2007-10-10 | 2011-01-06 | ウンファ コーポレーション | Anticancer composition comprising plant stem cell line derived from yew formation layer or pre-formation layer |
WO2010137877A3 (en) * | 2009-05-26 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family asteraceae and method for the isolated culturing thereof |
WO2010137878A3 (en) * | 2009-05-26 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family gingkoaceae and method for the isolation thereof |
WO2010137918A3 (en) * | 2009-05-28 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family solanaceae, and method for isolating and culturing same |
US20110117039A1 (en) * | 2005-10-31 | 2011-05-19 | Unhwa Corporation | Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient |
EP2335712A2 (en) * | 2008-08-14 | 2011-06-22 | Unhwa Corporation | Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient |
JP2011522884A (en) * | 2008-06-13 | 2011-08-04 | 株式会社ウンファ | Anti-aging or antioxidant composition comprising as an active ingredient a plant stem cell line derived from ginseng-forming ginseng or natural ginseng |
EP2353603A2 (en) * | 2008-11-06 | 2011-08-10 | Unhwa Corporation | Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng |
EP2363137A2 (en) * | 2008-09-30 | 2011-09-07 | Unhwa Corporation | Composition for preventing or treating aids containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient |
US8017397B2 (en) | 2005-10-31 | 2011-09-13 | Unhwa Corporation | Isolated population of plant single cells and method of preparing same |
US8053238B2 (en) | 2005-10-31 | 2011-11-08 | Unhwa Corporation | Isolated population of plant single cells and method of preparing the same |
EP2399596A2 (en) * | 2009-02-23 | 2011-12-28 | Unhwa Corporation | Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient |
WO2012052854A2 (en) * | 2010-10-23 | 2012-04-26 | Unhwa Corporation | Plant cell lines and methods of isolating the same |
CN103305455A (en) * | 2013-06-05 | 2013-09-18 | 林树芳 | Taxus chinensis plant stem cell line breeding and anticancer drug extracting and preparing method |
WO2024008874A1 (en) | 2022-07-06 | 2024-01-11 | Green Bioactives Limited | Method for isolating plant stem cells from plant leaves and the associated cell lines obtained utilising the method |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014221493B2 (en) | 2013-02-28 | 2017-02-16 | Wellkey Holdings Limited | Recombinant plant cell, preparation method therefor, and method for producing target protein using same |
MX2015018035A (en) * | 2013-07-03 | 2016-07-06 | Coyne Ip Holdings Llc | Methods for predicting responses to chemical or biologic substances. |
CN104783324B (en) * | 2015-03-17 | 2016-08-17 | 湖北中烟工业有限责任公司 | The preparation method of tobacco cell extract |
CN109652360B (en) * | 2019-01-11 | 2022-04-15 | 成都大学 | Notopterygium incisum cell culture method for obtaining high biological yield |
WO2020168141A1 (en) * | 2019-02-15 | 2020-08-20 | Muhammed Majeed | Method of isolating secondary metabolites from cambium derived callus cultures |
US11299700B1 (en) | 2021-02-19 | 2022-04-12 | Acequia Biotechnology, Llc | Bioreactor containers and methods of growing hairy roots using the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030063724A (en) * | 2002-01-23 | 2003-07-31 | 손성호 | Production method of Callus and Adventitious root from the leaves and stems of ginseng |
KR20040108052A (en) * | 2003-06-16 | 2004-12-23 | 진영우 | Method of plant cell culture from cambium |
EP1538214A1 (en) * | 1996-05-24 | 2005-06-08 | Phyton, Inc. | Enhanced production of taxanes by cell cultures of taxus species |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019504A (en) * | 1989-03-23 | 1991-05-28 | The United States Of America As Represented By The Secretary Of Agriculture | Production of taxol or taxol-like compounds in cell culture |
US5550318A (en) * | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5344775A (en) * | 1991-11-15 | 1994-09-06 | Escagenetics Corporation | Synthesis of taxanes in culture using pseudocalluscells |
US5407816A (en) * | 1992-02-20 | 1995-04-18 | Phyton Catalytic, Inc. | Enhanced production of taxol and taxanes by cell cultures of taxus species |
US5408816A (en) | 1994-06-27 | 1995-04-25 | Cartier; Lucille L. | Wheeled, hand-propelled carriages for horticultural devices |
KR970009157A (en) | 1995-07-08 | 1997-02-24 | 김광호 | How to specify the number of documents to send and receive faxes |
CN1146488A (en) * | 1995-09-27 | 1997-04-02 | 中国科学院昆明植物研究所 | Production technology for Taxales alcohol from Taxus chinensis cultured cell |
KR100290004B1 (en) | 1996-01-15 | 2001-05-15 | 허일섭 | Method for production of taxol and derivative thereof with high yield by cultivation of botanical cell of yew tree in a bioreactor |
KR100364478B1 (en) | 2000-04-04 | 2002-12-16 | 김인숙 | A method for high density cultures of plant cells using ultrasonic waves |
RU2398874C2 (en) * | 2005-10-31 | 2010-09-10 | Юнхва | Cell clones of cambium, method of recovery and preservation |
US8053238B2 (en) * | 2005-10-31 | 2011-11-08 | Unhwa Corporation | Isolated population of plant single cells and method of preparing the same |
KR101064518B1 (en) * | 2007-09-21 | 2011-09-19 | 주식회사 운화 | Plant Stem Cell line Derived from Cambium of Herbaceous Plant With Storage Root and Method for Isolating the Same |
KR101068971B1 (en) * | 2007-09-21 | 2011-09-30 | 주식회사 운화 | Plant Stem Cell Line Derived from Quiescent Center and Method for Isolating the Same |
AU2008202078B2 (en) | 2007-10-10 | 2012-05-31 | Wellkey Holdings Limited | Stability of secondary metabolite mass production through synchronized plant cell cultures |
KR101100867B1 (en) | 2008-05-14 | 2012-01-02 | 주식회사 운화 | Anti-oxidative, Anti-inflammatory or Anit-aging Composition Comprising Plant Stem Cell Line Derived from Cambium or Procambium of Taxus |
EP2308462A2 (en) | 2008-06-13 | 2011-04-13 | Unhwa Corporation | Composition for anti-aging or antioxidation containing plant stem cell lines derived from cambium of panax ginseng including wild ginseng and ginseng as active components |
KR101179171B1 (en) | 2008-08-14 | 2012-09-03 | 주식회사 운화 | Composition for Preventing or Treating Hepatitic Disease Comprising Plant Stem Cell Line Derived from Cambium of Panax ginseng Including Wild Ginseng or Ginseng |
CA2738825A1 (en) | 2008-09-30 | 2010-04-08 | Unhwa Corporation | Composition for preventing or treating aids comprising plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient |
US8617621B2 (en) | 2009-02-23 | 2013-12-31 | Unhwa Corporation | Composition for enhancing immunity containing plant stem cell line derived from cambium of Panax ginseng including wild ginseng or ginseng as an active ingredient |
-
2006
- 2006-04-25 RU RU2008121914/10A patent/RU2398874C2/en active
- 2006-04-25 WO PCT/KR2006/001544 patent/WO2007052876A1/en active Application Filing
- 2006-04-25 EP EP11174650.9A patent/EP2386626B1/en active Active
- 2006-04-25 BR BRC10619656-0A patent/BRPI0619656C1/en not_active Application Discontinuation
- 2006-04-25 PL PL06757522T patent/PL1951863T3/en unknown
- 2006-04-25 AU AU2006309568A patent/AU2006309568B8/en active Active
- 2006-04-25 ES ES06757522.5T patent/ES2546108T3/en active Active
- 2006-04-25 CA CA2627533A patent/CA2627533C/en active Active
- 2006-04-25 US US12/063,929 patent/US8017397B2/en active Active
- 2006-04-25 KR KR1020107029921A patent/KR101064519B1/en active IP Right Grant
- 2006-04-25 CN CN200680039945.8A patent/CN101297028B/en active Active
- 2006-04-25 EP EP06757522.5A patent/EP1951863B1/en active Active
- 2006-04-25 KR KR1020077030252A patent/KR101020689B1/en active IP Right Grant
- 2006-04-25 JP JP2008538791A patent/JP5211296B2/en active Active
-
2010
- 2010-09-23 US US12/889,026 patent/US20110033903A1/en not_active Abandoned
-
2012
- 2012-10-03 JP JP2012221126A patent/JP6026209B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1538214A1 (en) * | 1996-05-24 | 2005-06-08 | Phyton, Inc. | Enhanced production of taxanes by cell cultures of taxus species |
KR20030063724A (en) * | 2002-01-23 | 2003-07-31 | 손성호 | Production method of Callus and Adventitious root from the leaves and stems of ginseng |
KR20040108052A (en) * | 2003-06-16 | 2004-12-23 | 진영우 | Method of plant cell culture from cambium |
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8329471B2 (en) | 2005-10-31 | 2012-12-11 | Unhwa Corporation | Isolated population of plant single cells and method of preparing same |
US9585923B2 (en) * | 2005-10-31 | 2017-03-07 | Unhwa Corporation | Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient |
US8053238B2 (en) | 2005-10-31 | 2011-11-08 | Unhwa Corporation | Isolated population of plant single cells and method of preparing the same |
US8017397B2 (en) | 2005-10-31 | 2011-09-13 | Unhwa Corporation | Isolated population of plant single cells and method of preparing same |
US20110117039A1 (en) * | 2005-10-31 | 2011-05-19 | Unhwa Corporation | Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient |
JP2010539900A (en) * | 2007-09-21 | 2010-12-24 | ウンファ コーポレーション | Plant stem cell line derived from herbaceous plant with storage roots and method for separating the same |
EP2220211A4 (en) * | 2007-09-21 | 2011-01-05 | Unhwa Corp | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same |
US8247230B2 (en) | 2007-09-21 | 2012-08-21 | Unhwa Corporation | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same |
AU2008301352B2 (en) * | 2007-09-21 | 2012-11-29 | Wellkey Holdings Limited | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same |
CN103382453A (en) * | 2007-09-21 | 2013-11-06 | 云火公司 | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same |
EP2220211A2 (en) * | 2007-09-21 | 2010-08-25 | Unhwa Corporation | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolating the same |
JP2011500559A (en) * | 2007-10-10 | 2011-01-06 | ウンファ コーポレーション | Anticancer composition comprising plant stem cell line derived from yew formation layer or pre-formation layer |
US8790927B2 (en) | 2007-10-10 | 2014-07-29 | Unhwa Corporation | Anticancer method comprising plant stem cell line derived from Taxus cambium or procambium |
AU2008202078B2 (en) * | 2007-10-10 | 2012-05-31 | Wellkey Holdings Limited | Stability of secondary metabolite mass production through synchronized plant cell cultures |
JP2011520874A (en) * | 2008-05-14 | 2011-07-21 | 株式会社ウンファ | Antioxidant, anti-inflammatory or anti-aging composition containing yew genus formation layer or pre-formation layer-derived plant stem cell line as an active ingredient |
RU2520606C2 (en) * | 2008-05-14 | 2014-06-27 | Унхва Корпорейшн | Cosmetic composition containing culture cells of yew (taxus) stem cambium or procambium |
JP2011522884A (en) * | 2008-06-13 | 2011-08-04 | 株式会社ウンファ | Anti-aging or antioxidant composition comprising as an active ingredient a plant stem cell line derived from ginseng-forming ginseng or natural ginseng |
CN102159182A (en) * | 2008-06-13 | 2011-08-17 | 云火公司 | Composition for anti-aging or antioxidation containing plant stem cell lines derived from cambium of panax ginseng including wild ginseng and ginseng as active components |
US9095532B2 (en) | 2008-06-13 | 2015-08-04 | Unhwa Corporation | Composition for anti-aging or antioxidant composition containing plant stem cell line derived from cambium or Panax ginseng including wild ginseng and ginseng as active components |
EP2335712A2 (en) * | 2008-08-14 | 2011-06-22 | Unhwa Corporation | Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient |
EP2335712A4 (en) * | 2008-08-14 | 2012-08-01 | Unhwa Corp | Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient |
EP2363137A2 (en) * | 2008-09-30 | 2011-09-07 | Unhwa Corporation | Composition for preventing or treating aids containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient |
EP2363137A4 (en) * | 2008-09-30 | 2012-08-01 | Unhwa Corp | Composition for preventing or treating aids containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient |
US9314492B2 (en) * | 2008-11-06 | 2016-04-19 | Unhwa Corporation | Composition for cancer prevention or treatment containing as active ingredient plant stem cell line dervied from cambium of Panax ginseng including wild ginseng or ginseng |
EP2353603A2 (en) * | 2008-11-06 | 2011-08-10 | Unhwa Corporation | Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng |
US20110229443A1 (en) * | 2008-11-06 | 2011-09-22 | Unhwa Corporation | Composition for Cancer Prevention or Treatment Containing as Active Ingredient Plant Stem Cell Line Dervied from Cambium of Panax Ginseng Including Wild Ginseng or Ginseng |
JP2012507579A (en) * | 2008-11-06 | 2012-03-29 | 株式会社ウンファ | A composition for preventing or treating cancer comprising, as an active ingredient, a ginseng-forming plant stem cell line derived from natural ginseng or ginseng |
EP2353603A4 (en) * | 2008-11-06 | 2012-08-01 | Unhwa Corp | Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng |
EP2399596A2 (en) * | 2009-02-23 | 2011-12-28 | Unhwa Corporation | Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient |
EP2399596A4 (en) * | 2009-02-23 | 2012-08-29 | Unhwa Corp | Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient |
CN102459572A (en) * | 2009-05-26 | 2012-05-16 | 云火公司 | Plant stem cell derived from cambium of family gingkoaceae and method for isolation thereof |
WO2010137878A3 (en) * | 2009-05-26 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family gingkoaceae and method for the isolation thereof |
WO2010137877A3 (en) * | 2009-05-26 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family asteraceae and method for the isolated culturing thereof |
CN102459572B (en) * | 2009-05-26 | 2014-11-19 | 云火公司 | Plant stem cell derived from cambium of family gingkoaceae and method for isolation thereof |
WO2010137879A3 (en) * | 2009-05-26 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family salicaceae and method for isolating and culturing same |
WO2010137879A2 (en) * | 2009-05-26 | 2010-12-02 | 주식회사 운화 | Plant stem cell derived from cambium of family salicaceae and method for isolating and culturing same |
WO2010137918A3 (en) * | 2009-05-28 | 2011-04-14 | 주식회사 운화 | Plant stem cell derived from cambium of family solanaceae, and method for isolating and culturing same |
WO2012052854A2 (en) * | 2010-10-23 | 2012-04-26 | Unhwa Corporation | Plant cell lines and methods of isolating the same |
WO2012052854A3 (en) * | 2010-10-23 | 2012-08-02 | Unhwa Corporation | Plant cell lines and methods of isolating the same |
CN103305455A (en) * | 2013-06-05 | 2013-09-18 | 林树芳 | Taxus chinensis plant stem cell line breeding and anticancer drug extracting and preparing method |
WO2024008874A1 (en) | 2022-07-06 | 2024-01-11 | Green Bioactives Limited | Method for isolating plant stem cells from plant leaves and the associated cell lines obtained utilising the method |
Also Published As
Publication number | Publication date |
---|---|
US20080194025A1 (en) | 2008-08-14 |
EP1951863A4 (en) | 2009-05-20 |
KR101064519B1 (en) | 2011-09-19 |
PL1951863T3 (en) | 2015-12-31 |
CN101297028B (en) | 2016-01-20 |
RU2398874C2 (en) | 2010-09-10 |
US20110033903A1 (en) | 2011-02-10 |
US8017397B2 (en) | 2011-09-13 |
EP1951863B1 (en) | 2015-07-08 |
EP2386626B1 (en) | 2016-10-26 |
CA2627533C (en) | 2015-09-08 |
ES2546108T3 (en) | 2015-09-18 |
KR101020689B1 (en) | 2011-03-11 |
CN101297028A (en) | 2008-10-29 |
AU2006309568B2 (en) | 2012-03-15 |
RU2008121914A (en) | 2009-12-10 |
CA2627533A1 (en) | 2007-05-10 |
JP6026209B2 (en) | 2016-11-16 |
JP2009513157A (en) | 2009-04-02 |
KR20110004922A (en) | 2011-01-14 |
AU2006309568B8 (en) | 2012-04-05 |
JP2013031451A (en) | 2013-02-14 |
BRPI0619656A2 (en) | 2011-10-11 |
JP5211296B2 (en) | 2013-06-12 |
EP2386626A1 (en) | 2011-11-16 |
BRPI0619656C1 (en) | 2011-12-20 |
AU2006309568A1 (en) | 2007-05-10 |
KR20080029971A (en) | 2008-04-03 |
EP1951863A1 (en) | 2008-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8017397B2 (en) | Isolated population of plant single cells and method of preparing same | |
US8329471B2 (en) | Isolated population of plant single cells and method of preparing same | |
AU2008202078B2 (en) | Stability of secondary metabolite mass production through synchronized plant cell cultures | |
RU2467067C2 (en) | Plant stem cell line derived from cambium of herbaceous plant with storage root and method for isolation thereof | |
KR101211682B1 (en) | Plant Stem Cell Derived from Cambium of Family Solanaceae and Method of Isolating and Culturing the Same | |
US20100255585A1 (en) | Plant stem cell line derived from quiescent center and method for isolating the same | |
KR20100127724A (en) | Plant stem cell derived from cambium of family gingkoaceae and method of isolating the same | |
US10822628B2 (en) | Production of thapsigargins by thapsia cell suspension culture | |
CA2630150A1 (en) | Plant secondary metabolite production through syncronized procambium cell culture | |
KR20110003887A (en) | Plant stem cell derived from cambium or procambium of genus brassica and method for isolating the same | |
CN110317773A (en) | A kind of separation of dendrobium candidum suspension cell and cultural method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680039945.8 Country of ref document: CN |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020077030252 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12063929 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2627533 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2008538791 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2150/CHENP/2008 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006757522 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006309568 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006309568 Country of ref document: AU Date of ref document: 20060425 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008121914 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020107029921 Country of ref document: KR Ref document number: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0619656 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080430 |